glp 1 announcement Novo Nordisk, Lilly strike deal with Trump to slash weight-loss drug prices Medicaid Coverage of and Spending
Description
The RESTORE trial is ongoing, and longer-term data will be necessary to determine whether the observed reproductive benefits are sustained
Market Growth The global GLP-1 drugs market size was US$ 48.3 billion in 2024 and is forecast to increase to US$ 52.95 billion by 2025
One of its most impressive results was from one of the SCALE trials, in which Saxenda showed an 80% reduction in the progression of patients from pre-diabetes to diabetes over a three-year period
Vojtek AB, Taylor J, DeRuiter SL, Yu JY, Figueroa C, Kwok RP, et al
